Literature DB >> 21999708

Impact of decalcification on receptor status in breast cancer.

Farbod Darvishian, Baljit Singh, Stephanie Krauter, Luis Chiriboga, Maryann D Gangi, Jonathan Melamed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21999708     DOI： 10.1111/j.1524-4741.2011.01168.x

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  7 in total

Review 1.  Applying the New Guidelines of HER2 Testing in Breast Cancer.

Authors:  Huina Zhang; Ioana Moisini; Rana M Ajabnoor; Bradley M Turner; David G Hicks
Journal:  Curr Oncol Rep       Date:  2020-04-29       Impact factor: 5.075

2.  Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.

Authors:  Gary A Ulaner; David M Hyman; Dara S Ross; Adriana Corben; Sarat Chandarlapaty; Shari Goldfarb; Heather McArthur; Joseph P Erinjeri; Stephen B Solomon; Hartmuth Kolb; Serge K Lyashchenko; Jason S Lewis; Jorge A Carrasquillo
Journal:  J Nucl Med       Date:  2016-05-05       Impact factor: 10.057

3.  Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Catherine Van Poznak; Mark R Somerfield; Robert C Bast; Massimo Cristofanilli; Matthew P Goetz; Ana M Gonzalez-Angulo; David G Hicks; Elizabeth G Hill; Minetta C Liu; Wanda Lucas; Ingrid A Mayer; Robert G Mennel; William F Symmans; Daniel F Hayes; Lyndsay N Harris
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

4.  Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.

Authors:  Willemijne A M E Schrijver; Petra van der Groep; Laurien Dc Hoefnagel; Natalie D Ter Hoeve; Ton Peeters; Cathy B Moelans; Paul J van Diest
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

5.  Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.

Authors:  Jennifer Zeng; Salvatore Piscuoglio; Gitika Aggarwal; Joanna Magda; Maria A Friedlander; Melissa Murray; Muzaffar Akram; Jorge S Reis-Filho; Britta Weigelt; Marcia Edelweiss
Journal:  Cancer Cytopathol       Date:  2019-12-28       Impact factor: 5.284

6.  Testing for her2 in breast cancer: current pathology challenges faced in Canada.

Authors:  W Hanna; P Barnes; R Berendt; M Chang; A Magliocco; A M Mulligan; H Rees; N Miller; L Elavathil; B Gilks; N Pettigrew; D Pilavdzic; S Sengupta
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

7.  Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.

Authors:  Vincent Walter; Chiara Fischer; Thomas M Deutsch; Catherine Ersing; Juliane Nees; Florian Schütz; Carlo Fremd; Eva-Maria Grischke; Peter Sinn; Sara Y Brucker; Andreas Schneeweiss; Andreas D Hartkopf; Markus Wallwiener
Journal:  Breast Cancer Res Treat       Date:  2020-07-01       Impact factor: 4.872
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.